TGFB1 and Parkinson disease: In summary, this study demonstrated that downregulation of LncRNA MIAT alleviated neuronal inflammation and oxidative stress in PD via targeting miR-221-3p/TGF-β1/Nrf2 axis and providing a potential target for PD treatment.